Red cells II: Acquired anaemias and polycythaemia

Lancet

Volumn 355, Issue 9211, 2000, Pages 1260-1268

  Provan, Drew ^a   Weatherall, David ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; HYDROXOCOBALAMIN; IRON; METHOTREXATE; TRIMETHOPRIM;

ANEMIA; APLASTIC ANEMIA; CYANOCOBALAMIN DEFICIENCY; ERYTHROCYTE; ERYTHROPOIESIS; FOLIC ACID DEFICIENCY; HEMOCHROMATOSIS; HEMOLYTIC ANEMIA; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON TRANSPORT; MACROCYTIC ANEMIA; MYELODYSPLASTIC SYNDROME; POLYCYTHEMIA; PRIORITY JOURNAL; REVIEW;

EID: 0034621061     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02099-7     Document Type: Review

References (43)

1. Cook J.D., Skikne B.S., Baynes R.D. Iron deficiency. the global perspective Adv Exp Med Biol. 356:1994;219-228.
2. Provan D. Mechanisms and management of iron deficiency anaemia. Br J Haematol. 105:1999;19-26. (suppl 1).
3. Gunshin H., Mackenzie B., Berger U.V.et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.
4. Seligman P.A., Schleicher R.B., Allen R.H. Isolation and characterization of the transferrin receptor from human placenta. J Biol Chem. 254:1979;9943-9946.
5. Kohgo Y., Niitsu Y., Nishisato T.et al. Quantitation and characterization of serum transferrin receptor in patients with anemias and polycythemias. Jpn J Med. 27:1988;40-67.
6. Zoller H., Pietroangelo A., Vogel W., Weiss G. Duodenal metal transporter (DMT-1, NRAMP-2) expression in patients with hereditary haeochromatosis. Lancet. 353:1999;2120-2123.
7. Feder J.N., Gnirke A., Thomas W.et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-408.
8. Waheed A., Parkkila S., Saarnio J.et al. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci USA. 96:1999;1579-1584.
9. Gray N.K., Hentze M.W. Iron regulatowry protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs. EMBO J. 13:1994;3882-3891.
10. Kaptain S., Downey W.E., Tang C.et al. A regulated RNA binding protein also possesses aconitase activity. Proc Natl Acad Sci USA. 88:1991;10109-10113.
11. Mullner E.W., Kuhn L.C. A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell. 53:1988;815-825.
12. Means R.T., Krantz S.B. Progress in understanding the pathogenesis of the anemia in chronic disease. Blood. 80:1992;1639-1647.
13. Baer A.N., Dessypris E.N., Krantz S.B. The pathogenesis of anemia in rheumatoid arthritis. a clinical and laboratory analysis Semin Arthritis Rheum. 19:1990;209-223.
14. Pippard M.J., Hoffbrand A.V. Iron. Hoffbrand A.V., Lewis S.M., Tuddenham E.G.D. Postgraduate haematology, 4th edn. 1999;23-46 Butterworth-Heinemann, Oxford.
15. Wickramasinghe S.N. Morphology, biology and biochemistry of cobalamin-and folate-deficient bone marrow cells. Baillieres Clin Haematol. 8:1995;441-459.
16. Savage D.G., Lindenbaum J. Neurological complications of acquired cobalamin deficiency. clinical aspects Baillieres Clin Haematol. 8:1995;657-678.
17. Molloy A.M., Daly S., Mills J.L.et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates. implications for folate intake recommendations Lancet. 349:1997;1591-1593.
18. Spivak J.L. Masked megaloblastic anemia. Arch Intern Med. 142:1982;2111-2114.
19. Hussein S., Laulicht M., Hoffbrand A.V. Serum ferritin in megaloblastic anaemia. Scand J Haematol. 20:1978;241-245.
20. Winston R.M., Warburton F.G., Stott A. Enzymatic diagnosis of megaloblastic anaemia. Br J Haematol. 19:1970;587-592.
21. Toh B.H., van Driel I.R., Gleeson P.A. Pernicious anemia. N Engl J Med. 337:1997;1441-1448.
22. Chanarin I., Metz J. Diagnosis of cobalamin deficiency. the old and the new Br J Haematol. 97:1997;695-700.
23. Fairbanks V.F., Wahner H.W., Phyliky R.L. Tests for pernicious anemia. the Schilling test Mayo Clin Proc. 58:1983;541-544.
24. Callender S.T., Witts L.J., Warner G.T., Oliver R. The use of a simple whole-body counter for haematological investigations. Br J Haematol. 12:1966;276-282.
25. Folic acid and the prevention of neural tube defect. 1992;Department of Health, London.
26. Hoffbrand A.V. Megaloblastic anaemia. Hoffbrand A.V., Lewis S.M., Tuddenham E.G.D. Postgraduate haematology, 4th edn. 1999;47-67 Butterworth-Heinemann, Oxford.
27. Dacie J.V. Autoimmune haemolytic anaemias. 1992;Churchill Livingstone, Edinburgh.
28. Petz L.D. Drug-induced autoimmune hemolytic anemias. Transfus Med Rev. 7:1993;242-254.
29. Gordon-Smith E.C., Hows J.M., Luzzatto L. Acquired haemolytic anaemias. Hoffbrand A.V., Lewis S.M., Tuddenham E.G.D. Postgraduate haematology, 4th edn. 1999;144-163 Butterworth-Heinemann, Oxford.
30. Hallberg L., Magnusson B. The etiology of "sports anemia" a physiological adaptation of the oxygen-dissociation curve of hemoglobin to an unphysiological exercise load Acta Med Scand. 216:1984;147-148.
31. Passmore S.J., Hann I.M., Stiller C.A.et al. Pediatric myelodysplasia. a study of 68 children and a new prognostic scoring system Blood. 85:1995;1742-1750.
32. Bennett J.M., Catovsky D., Daniel M.T.et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 51:1982;189-199.
33. Boultwood J., Lewis S., Wainscoat J.S. The 5q- syndrome. Blood. 84:1994;3253-3260.
34. Anderson J.E., Anasetti C., Appelbaum F.R.et al. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia. Br J Haematol. 93:1996;59-67.
35. Rosse W.F., Ware R.E. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood. 86:1995;3277-3286.
36. Socie G., Mary J.Y., de Gramont A.et al. Paroxysmal nocturnal haemoglobinuria. long-term follow-up and prognostic factors Lancet. 348:1996;573-577.
37. Gordon-Smith E.C., Lewis S.M. Aplastic anaemia and other types of bone marrow failure. Hoffbrand A.V., Lewis S.M., Tuddenham E.G.D. Postgraduate haematology. 4th edn. 1999;68-90 Butterworth-Heinemann, Oxford.
38. Champlin R.E., Feig S.A., Sparkes R.S., Galen R.P. Bone marrow transplantation from identical twins in the treatment of aplastic anaemia. implication for the pathogenesis of the disease Br J Haematol. 56:1984;455-463.
39. Camitta B.M., Thomas E.D., Nathan D.G.et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood. 53:1979;504-514.
40. de Planque M.M., Kluin-Nelemans H.C., van Krieken H.J.et al. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol. 70:1988;55-62.
41. Berlin N.I. Polycythemia vera. Semin Hematol. 34:1997;1-80.
42. Pearson T.C. Apparent polycythaemia. Blood Rev. 5:1991;205-213.
43. Bench A.J., Huntly B.J.P., Nacheva E.P., Champion K.M., Green A.R. Myeloproliferative disorders. Provan D., Gribben J.G. Molecular haematology. 2000;Blackwell Science, Oxford.